FATE THERAPEUTICS INC (FATE) Revenue 2016–2025
FATE THERAPEUTICS INC (FATE) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$6.6MFY2025 · since FY2016: $4.4M → $6.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.6M | -51.2% |
| FY2024 | $13.6M | -78.5% |
| FY2023 | $63.5M | -34.0% |
| FY2022 | $96.3M | +72.4% |
| FY2021 | $55.8M | +77.7% |
| FY2020 | $31.4M | +194.3% |
| FY2019 | $10.7M | +125.3% |
| FY2018 | $4.7M | +15.4% |
| FY2017 | $4.1M | -6.7% |
| FY2016 | $4.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FATE financial trends
FATE Net incomeFATE Net marginFATE Gross profitFATE Gross marginFATE Operating incomeFATE Operating marginFATE Operating cash flowFATE Free cash flowFATE Capital expendituresFATE Return on equityFATE Stock buybacksFATE Dividends paidFATE Total assetsFATE Total liabilitiesFATE Shareholders’ equityFATE overview →